PT Kalbe Farma Tbk. (PTKFF)
PTKFF Stock Price Chart
Explore PT Kalbe Farma Tbk. interactive price chart. Choose custom timeframes to analyze PTKFF price movements and trends.
PTKFF Company Profile
Discover essential business fundamentals and corporate details for PT Kalbe Farma Tbk. (PTKFF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
8 Jan 2002
Employees
12.84K
Website
https://www.kalbe.co.idCEO
Bernadette Ruth Irawati Setiady
Description
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. The company also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, it offers contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products, as well as operates Mitrasana Clinics, a health care service. Further, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
PTKFF Financial Timeline
Browse a chronological timeline of PT Kalbe Farma Tbk. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 26 Mar 2026
Upcoming earnings on 28 Oct 2025
Earnings released on 31 Jul 2025
EPS came in at $19.46 surpassing the estimated $0.00 by +1.64M%, while revenue for the quarter reached $8.23T , beating expectations by +1.61M%.
Dividend declared on 26 May 2025
A dividend of $0.00 per share was announced, adjusted to $0.00. The dividend was paid on 25 Jun 2025.
Earnings released on 30 Apr 2025
EPS came in at $23.33 surpassing the estimated $0.00 by +1.93M%, while revenue for the quarter reached $8.85T , beating expectations by +0.64%.
Earnings released on 28 Mar 2025
EPS came in at $18.68 surpassing the estimated $0.00 by +1.81M%, while revenue for the quarter reached $8.39T , beating expectations by +1.61M%.
Earnings released on 30 Oct 2024
EPS came in at $12.42 surpassing the estimated $0.00 by +1.25M%, while revenue for the quarter reached $7.91T .
Earnings released on 31 Jul 2024
EPS came in at $18.33 surpassing the estimated $0.00 by +1.78M%, while revenue for the quarter reached $7.97T .
Dividend declared on 21 May 2024
A dividend of $0.00 per share was announced, adjusted to $0.00. The dividend was paid on 14 Jun 2024.
Earnings released on 1 May 2024
EPS came in at $20.70 surpassing the estimated $0.00 by +1.82M%, while revenue for the quarter reached $8.36T , beating expectations by +1.66M%.
Earnings released on 30 Dec 2023
EPS came in at $15.17 surpassing the estimated $0.00 by +1.47M%, while revenue for the quarter reached $7.89T , beating expectations by +1.54M%.
Earnings released on 30 Sept 2023
EPS came in at $11.59 surpassing the estimated $0.00 by +1.02M%, while revenue for the quarter reached $7.38T , beating expectations by +1.47M%.
Earnings released on 30 Jun 2023
EPS came in at $14.56 surpassing the estimated $0.00 by +1.10M%, while revenue for the quarter reached $7.31T , beating expectations by +1.44M%.
Dividend declared on 8 May 2023
A dividend of $0.00 per share was announced, adjusted to $0.00. The dividend was paid on 31 May 2023.
Earnings released on 31 Mar 2023
EPS came in at $18.40 surpassing the estimated $0.00 by +1.43M%, while revenue for the quarter reached $7.87T , beating expectations by +1.51M%.
Earnings released on 31 Dec 2022
EPS came in at $19.39 surpassing the estimated $0.00 by +1.48M%, while revenue for the quarter reached $7.75T , beating expectations by +1.56M%.
Earnings released on 31 Oct 2022
EPS came in at $18.33 falling short of the estimated $18.68 by -1.87%, while revenue for the quarter reached $7.31T .
Earnings released on 29 Jul 2022
EPS came in at $17.26 falling short of the estimated $18.79 by -8.14%, while revenue for the quarter reached $6.86T .
Dividend declared on 27 May 2022
A dividend of $0.00 per share was announced, adjusted to $35.00. The dividend was paid on 22 Jun 2022.
Earnings released on 28 Apr 2022
EPS came in at $17.85 falling short of the estimated $18.30 by -2.46%, while revenue for the quarter reached $7.16T .
Earnings released on 31 Mar 2022
EPS came in at $19.11 surpassing the estimated $16.98 by +12.54%, while revenue for the quarter reached $7.02T , beating expectations by +1.40M%.
Earnings released on 25 Oct 2021
EPS came in at $16.87 surpassing the estimated $15.11 by +11.65%, while revenue for the quarter reached $6.73T .
Earnings released on 30 Jul 2021
EPS came in at $16.65 surpassing the estimated $15.84 by +5.11%, while revenue for the quarter reached $6.36T .
Dividend declared on 2 Jun 2021
A dividend of $0.00 per share was announced, adjusted to $0.00. The dividend was paid on 30 Jun 2021.
Earnings released on 3 May 2021
EPS came in at $15.29 surpassing the estimated $14.74 by +3.73%, while revenue for the quarter reached $6.02T .
Earnings released on 31 Mar 2021
EPS came in at $15.29 , while revenue for the quarter reached $6.02T .
Dividend declared on 27 Nov 2020
A dividend of $0.00 per share was announced, adjusted to $6.00. The dividend was paid on 18 Dec 2020.
Earnings released on 30 Oct 2020
EPS came in at $13.65 falling short of the estimated $14.52 by -5.99%, while revenue for the quarter reached $5.49T .
PTKFF Stock Performance
Access detailed PTKFF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.